Chronic Exposure With 5-Alpha Reductase Inhibitor Ameliorates Anxiety and Depression-Like Behaviors by Reducing Systemic Oxidative Stress in D-Galactose-Induced Aging Male Rats

    December 2023 in “ Alzheimer's & dementia
    Hiranya Pintana, Thiraphat Saengmearnuparp, Nattayaporn Apaijai, Titikorn Chunchai, Bannakij Lojanapiwat, Nipon Chattipakorn, Nipon Chattipakorn
    Image of study
    TLDR Finasteride may help reduce anxiety and depression in elderly but might cause depression in young men.
    The study investigated the effects of finasteride (Fin), a 5-alpha reductase inhibitor, on anxiety and depression-like behaviors in D-galactose (D-gal)-induced aging male rats. Twenty male Wistar rats were divided into two groups, with one group receiving D-gal to induce aging. At week 13, each group was further divided to receive either Fin or a vehicle. The results showed that D-gal increased systemic oxidative stress and induced anxiety and depression-like behaviors. Fin treatment in D-gal rats reduced these behaviors, likely due to decreased oxidative stress. However, Fin also caused metabolic disturbances and depression-like behaviors in control rats. The findings suggest potential therapeutic use of Fin for anxiety and depression in the elderly, but caution is advised for its use in young men due to possible depressive effects.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Just popped my first fin, excited as hell!

      in Finasteride/Dutasteride  154 upvotes 5 months ago
      A user shared their excitement about starting finasteride for hair loss after trying various ineffective methods. Other users discussed their experiences with finasteride, including shedding phases and side effects, with one mentioning using topical finasteride and minoxidil.

      community NW5 at 19. How many grafts do I need?

      in Transplants  140 upvotes 1 year ago
      A 19-year-old with rapid hair loss since 16 is considering a hair transplant but refuses to take finasteride or any 5α-Reductase inhibitors. They are currently using minoxidil, tretinoin, and microneedling with a Derminator 2, and only want hair until age 27.

    Similar Research

    5 / 1000+ results